Abstract: The first total synthesis of cannabimovone from Cannabis sativa and anhydrocannabimovone was achieved by means of ah ighly stereoselective gold(I)-catalyzed cycloisomerization. The results led to reassignment of the structure of anhydrocannabimovone.
The herbaceous plant Cannabis sativa has been used in medicine for centuries and still attracts significant interest due to the biological and pharmaceutical activity of many of its metabolites. [1] More than 60 compounds,k nown as cannabinoids (a group of C 21 terpenophenolic compounds), are exclusively found in Cannabis sativa. [2] Owing to the development of synthetic cannabinoids, [3, 4] theunique components of Cannabis sativa are known as phytocannabinoids.T he most abundant compound is D
9
-tetrahydrocannabinol (THC, 1; Figure 1 ), which shows interesting pharmacological activity as an analgesic,a ntiemetic,a nd appetite stimulant, among others,b esides its well-known psychotropic effects. [5] Several total syntheses of 1 have been accomplished to date. [6] Cannabidiol (CBD, 2)isanother important phytocannabinoid with great potential as ad rug [7] since it modulates the undesired effects of THC when they are administrated together. [8] As tructurally different cannabinoid named cannabimovone (3)h as recently been isolated by the groups of Taglialatela-Scafati and Appendino from an onpsychotropic variety of hemp (Cannabis sativa L.;F igure 1). [9] In their attempt at preparing 3 from CBD (2)t hrough an intramolecular aldol reaction of keto aldehyde 4 under mild acidic conditions,the product of dehydration (5)was formed instead (Scheme 1). Under basic conditions,t he novel cannabinoid anhydrocannabimovone (6)w as directly formed through an intramolecular oxy-Michael addition of one of the phenol groups to the intermediate enone.Synthetic 6 was found to be active against metabotropic and ionotropic cannabinoid receptors,s howing as imilar biological profile to THC, whereas cannabimovone (3)h as affinity only for ionotropic receptors. [9] Theunprecedented abeo-menthane terpenoid structure of cannabimovone (3)i ncludes ad ensely functionalized cyclopentane with four contiguous stereocenters.T he novel structure of 3,c oupled with its lability towards dehydration under acidic or basic conditions and the interesting biological profiles of both 3 and 6,i nspired us to develop at otal synthesis that could allow access to aw ide variety of analogues.H erein, we report the first total synthesis of enantiopure cannabimovone (3)and also revise the structure originally assigned to anhydrocannabimovone from transfused 6' ' to cis-tetrahydro-1H-cyclopenta[b]benzofuran 6.Our approach to the synthesis of these compounds relies on agold(I)-catalyzed cycloisomerization [10] [11] [12] [13] [14] [15] of aryl-substituted 1,5-enyne 7,w hich could be obtained in af ew steps from commercially available (+ +)-methyl (S)-3-hydroxybutyrate (9; Scheme 2).
Thes ynthesis commenced with alkylation of the lithium enolate of 9 with prenyl bromide to provide known compound 10 with excellent diastereoselectivity (98:2) by following aslight modification of the reported procedure [16] (Scheme 3). Protection of the alcohol of 10 as as ilyl ether,c onversion of the ester into an aldehyde by at wo-step procedure (DIBAL reduction/Swern oxidation), and subsequent homologation with the Ohira-Bestmann reagent led to 1,5-enyne 11 (31 % over 5steps). Sonogashira coupling of 11 with iodo arene 12, prepared in two steps from olivetol, gave 7 in 83 %y ield on am ulti-gram scale.T he gold(I)-catalyzed cyclization of 1,5-enyne 7 was highly solvent dependent. Exposing 7 to the cationic gold(I) complex [(JohnPhos)Au(MeCN)]SbF 6 in CH 2 Cl 2 led to bicyclicc ompound 13 (49 %). As imilar result was obtained using other solvents such as Et 2 Oo rt oluene. Reaction in MeOH afforded methyl ether 14 (93 %). However,w hen the reaction was performed in DMSO,c yclopentene 8 was obtained in excellent yield (88 %). This reaction was performed up to a2 .1 gs cale.Asimilar result was observed when the reaction was performed in DMF (79 %). Presumably,t he initial intermediate of the gold(I)-catalyzed cyclization (Int)u ndergoes proton elimination assisted by the solvent to give 8 after protodeauration. Notably,t he gold-catalyzed cyclization led exclusively to the product with the correct relative configuration, thereby setting two of the final four stereocenters.
Although deprotection of the TBS group of 8 followed by oxidation of the alcohol to the methyl ketone could be carried out uneventfully,i somerization to form the a,b-unsaturated ketone failed under all the conditions we examined with this and with other intermediates with different phenol protecting groups.F ortunately,t he desired functionality in the fivemembered ring could be introduced by epoxidation with mCPBAa nd NaHCO 3 to exclusively form 15,f ollowed by Meinwald rearrangement with stoichiometric BF 3 ·Et 2 Ot o give ketone 16 (2,3-cis). Epimerization and cleavage of the silyl ether was achieved with aqueous HCl to give 17 (Scheme 4). Therelative configuration of 17 was determined by NMR studies and was confirmed by preparation of the same compound by adifferent route,namely cleavage of the TBS group of 8 followed by epoxidation to give 18,w hich underwent Meinwald rearrangement to provide 17.D iastereoselective reduction of b-hydroxy ketone 17 by SaksenaEvans reaction with NaBH(OAc) 3 in CH 2 Cl 2 afforded diol 19. Protection with AllocCl, which proceeded with moderate selectivity,followed by Dess-Martin oxidation gave protected cannabimovone 20.C leavage of the MOM groups using MgBr 2 and BnSH, [17] followed by Pd 0 deprotection of the allyl carbonate provided 3 (53 %o ver 2steps). Thes pectral data and optical rotation of the synthetic cannabimovone (3) matched those reported for the natural compound. [18] Whereas the synthesis of 3 fully supported the assigned configuration for all of the intermediates,acrystalline oxabicycle intermediate 21 was obtained through treatment of epoxide 18 with aBrønsted acid, which led to opening of the epoxide and trapping of the benzylic carbocation by the free alcohol (Scheme 5). Them olecular structure of 21 was determined by X-ray diffraction, which confirmed the relative configuration between the isopropenyl and the hydroxyethyl substituents.
[19] Treatment of 21 with ZnI 2 effected ap inacol rearrangement to give ketone 17.
Thes ynthesis of anhydrocannabimovone (6)w as carried out from acetate 22 by MOM cleavage followed by treatment with K 2 CO 3 to promote the oxy-Michael addition. Under these conditions,t wo separable epimers (6 and 6'')w ere formed in a4 :1 ratio (Scheme 6). Surprisingly,a lthough 1 HNMR of the major isomer 6 was identical to that reported for anhydrocannabimovone,very significant differences were observed in the 13 CNMR spectrum. [20] Furthermore,t he optical rotation of 6 ( CHCl 3 ) ). [9] Thes tructure of anhydrocannabimovone (6)w as finally confirmed by X-ray diffraction [19] and its absolute configuration was assigned on the basis of the X-ray structure of anhydrocannabimovone 2-bromobenzoate (23; Figure 2 ). [19] In order to clarify the discrepancy between our structural assignment and that originally reported, [9] we performed DFT calculations to study the oxy-Michael cyclization. Under basic conditions,o xy-Michael cyclization of the phenolate anion leads to cis fusion, which is more favored than the trans addition by 19.8 Kcal mol À1 (Figure 3) . [21] Furthermore,D FT calculations were employed to predict the expected 13 CNMR chemical shifts of the different possible products.
[22] Our data were in better agreement with the cis-tetrahydro-1H- cyclopenta[b]benzofuran structure for anhydrocannabimovone (6). [20] In conclusion, we have accomplished the first total synthesis of cannabimovone (3) . Thefour stereogenic centers of the target molecule were set up starting from the stereogenic center present in commercially available (+ +)-methyl (S)-3-hydroxybutyrate (9)a nd by using af ully diastereoselective gold(I)-catalyzed cyclization. Interestingly, this is the first example of the cycloisomerization of simple 1,5-enynes into 3-vinylcyclopent-1-enes catalyzed by gold in the context of natural product synthesis.W ealso synthesized anhydrocannabimovone (6)a nd revised the stereochemistry at the ring fusion by X-ray crystallography and DFT calculations.T his synthetic endeavor provides ready access to 3 and 6,a sw ell as other synthetic cannabinoids,f or biological testing.
